Last June, Meiji Seika Pharma Co. Ltd celebrated the “Meiji Seika Pharma Group FY 2022-23 Awards,” an annual ceremony that recognizes the progress and achievements of all the subsidiaries within the group.

This year, the Spanish subsidiary, Meiji Pharma Spain, S.A., was honored and recognized as the best subsidiary, receiving the “Outstanding Performance Award.”

This award not only acknowledges the evolution and results achieved in 2022 but also recognizes the implementation of the group’s strategy as a significant factor in attaining these results.

The journey to this recognition has not been easy, but thanks to the dedicated team of professionals in the company, Meiji has demonstrated its ability to overcome difficulties and adapt to circumstances.

Therefore, we would like to extend this recognition and gratitude to all members of the company for their hard work and unwavering dedication in facing the challenges presented to us, helping us progress and become better every day.

Thank you all for your involvement.

Congratulations!